* Laboratory Corporation of America Holdings LH.N reported
quarterly adjusted earnings of $4.68 per share for the quarter
ended in September. The mean expectation of fourteen analysts
for the quarter was for earnings of $4.67 per share.
* Revenue fell 11.2% to $3.61 billion from a year ago;
analysts
expected $3.79 billion.
* Laboratory Corporation of America Holdings's reported EPS
for
the quarter was $3.89.
* The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.
* In the last 30 days two analysts negatively revised
earnings
estimates
* Laboratory Corporation of America Holdings shares
had risen
by 12.3% this quarter and lost 26.8% so far this year.
* The company reported quarterly net income of $352.8
million.
* Wall Street's median 12-month price target for Laboratory
Corporation of America Holdings is $300.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data October
27 at 01:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 4.67 4.68 Beat
Jun. 30 2022 4.70 4.95 Beat
Mar. 31 2022 5.98 6.11 Beat
Dec. 31 2021 5.80 6.77 Beat